Tactile Systems Technology (TCMD) Capital Expenditures Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 116.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.62% |
| Dec 31, 2025 | 10.87% |
| Sep 30, 2025 | 18.11% |
| Jun 30, 2025 | -26.20% |
| Mar 31, 2025 | -21.37% |
| Dec 31, 2024 | -48.89% |
| Sep 30, 2024 | 149.34% |
| Jun 30, 2024 | -37.66% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 1,736.73% |
| Sep 30, 2023 | -72.79% |
| Jun 30, 2023 | 301.00% |
| Mar 31, 2023 | 83.97% |
| Dec 31, 2022 | -94.44% |
| Sep 30, 2022 | 126.54% |
| Jun 30, 2022 | -43.50% |
| Mar 31, 2022 | -47.39% |
| Dec 31, 2021 | 102.29% |
| Sep 30, 2021 | -35.83% |
| Jun 30, 2021 | 17.22% |
| Mar 31, 2021 | -30.45% |
| Dec 31, 2020 | -62.74% |
| Sep 30, 2020 | -61.72% |
| Jun 30, 2020 | -70.65% |
| Mar 31, 2020 | -51.03% |
| Dec 31, 2019 | -35.43% |
| Sep 30, 2019 | 267.84% |
| Jun 30, 2019 | -18.85% |
| Mar 31, 2019 | 69.21% |
| Dec 31, 2018 | 1.06% |
| Sep 30, 2018 | 56.52% |
| Jun 30, 2018 | 55.39% |
| Mar 31, 2018 | -38.29% |
| Dec 31, 2017 | 597.67% |
| Sep 30, 2017 | 112.14% |
| Jun 30, 2017 | 308.00% |
| Mar 31, 2017 | 525.00% |
| Dec 31, 2016 | 49.42% |
| Sep 30, 2016 | 29.56% |